Note: Ingredients listed on restricted chemical lists
EC/CAS
209-358-4/573-58-0
Name of the chemical
C.I. Direct Red 28
Concentration
100%
General Information
Version
1.0
Revision date
2024-03-05
Product name
CONGO RED INDICATOR FOR MICROSCOPY
Substance name
CONGO RED INDICATOR FOR MICROSCOPY
Product Synonyms
Direct Red 28, Congo Red 4B, Cosmos Red
CAS No.
573-58-0
Emergency telephone
91 22 6663 6663
Icons in SDS
Company Information
company name
LOBA CHEMIE PVT. LTD
e-mail address of the competent person responsible for the Safety Data Sheet
info@lobachemie.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H350, H361d
Hazard statements
Code
Statements
H350
May cause cancer
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
May cause cancer. Suspected of damaging fertility or the unborn child
Hazard pictograms
GHS08
Signal word
Danger
Hazard statements
H350 - May cause cancer. H361d - Suspected of damaging the unborn child.
Precautionary statements
P201 - Obtain special instructions before use. P280 - Wear protective clothing, eye protection, face protection, protective gloves. P308+P313 - IF exposed or concerned: Get medical advice/attention.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH CONGO RED INDICATOR (573-58-0) regulation, in accordance with Annex XIII Substance(s) not meeting the vPvB criteria of REACH CONGO RED INDICATOR (573-58-0) regulation, in accordance with Annex XIII The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Carcinogenicity, Category 1B H350 Reproductive toxicity, Category 2 H361d Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May cause cancer. Suspected of damaging fertility or the unborn child.
